Hi Anzu Partners Community,

This month, I’m excited to share some big news: the launch of Lex Generalis, a law firm created specifically for startups, research institutions, and technology innovators.

At Anzu, we’ve seen time and again how unpredictable and expensive legal services can decimate a company’s runway. Founders hesitate to call counsel because they’re worried about the billable hour, or they end up spending their own valuable time drafting NDAs and reviewing contracts instead of building their business. We’ve watched teams delay protecting their intellectual property simply because they were worried about the cost. These are avoidable distractions and costly mistakes.

Lex Generalis was built to change that. The firm offers a flat-fee model to make legal spend predictable and delivers the core corporate and intellectual property services companies actually need to grow. That means everything from patent filings to cap table management, to an “always-on” data room that keeps investors confident and deals moving. By combining experienced attorneys, engineers, and operators with the use of technology and AI, the Lex team is helping founders stay focused on building transformational technologies.

I’m incredibly proud of this launch—not only because it fills a gap we’ve seen across the innovation ecosystem, but because it reflects our commitment to solving problems creatively, even when the solution doesn’t look like a traditional venture investment. Lex Generalis is already making a difference for companies like BioFlyte and Xendee, and I can’t wait to see how many more startups and researchers it can empower outside of the Anzu ecosystem as well.

Sincerely,

Cathryn Paine, Partner at Anzu Partners and CEO of Lex Generalis

PORTFOLIO COMPANY UPDATES

BioSkryb Genomics Obtained an Exclusive License to Breakthrough Patent

BioSkryb Genomics announced the acquisition of an exclusive license to a patent co-owned by Stanford University and the Chan Zuckerberg Biohub in San Francisco that covers a method for combined single-cell DNA methylation and genome variation analyses.

The licensed technology will allow BioSkryb to create products helping researchers the analyze epigenetic state and genetic change in the same single cell, giving them further insight into research in oncology and neurology.

“Customers have been clear: they want detailed insights on both methylation and variants from the same cell, without compromising sample integrity,” said Suresh Pisharody, Chief Executive Officer, BioSkryb Genomics. “BioSkryb aims to bring this exclusively licensed capability to market as quickly and efficiently as possible, after rigorous validation.”

The news was covered in GenomeWeb* and DNAReads.

*Requires subscription to read

BioFlyte Awarded US Department of Homeland Security SAFETY Act Designation for Anti-Terrorism Technology

BioFlyte, a chemical and bioaerosol surveillance firm, announced that the US Department of Homeland Security has awarded the company a SAFETY Act Designation for its biothreat detection and identification technology. This recognition as a Qualified Anti-Terrorism Technology illustrates the reliability of BioFlyte’s solutions in detecting and mitigating airborne chemical and biological threats.

“We are honored to receive the DHS SAFETY Act Designation, which not only validates the strength and dependability of our technology but also provides meaningful protections for our customers,” said Todd Sickles, CEO of BioFlyte. “This achievement reflects DHS’ confidence in the reliability, predictability and consistent performance of our technology and it further differentiates BioFlyte in the marketplace.”

AM Batteries Launched its First Interactive Savings Calculator for Dry Electrode Manufacturing

AM Batteries (AMB), a pioneer in dry battery electrode manufacturing technology, announced their interactive Savings Calculator, the first of its kind for AMB, that enables battery makers to efficiently quantify the financial and performance impact of adopting AMB’s Powder to Electrode™ dry-coating process.

AMB’s tool shows cell makers $100M+ annual savings from dry electrode manufacturing.

“This tool transforms the value of dry electrode from theory into data,” said Lie Shi, CEO of AMB. “Within minutes, manufacturers can see how our Powder to Electrode™ process impacts their cost structure and the performance of the cells they produce.”

 Nirrin Technologies Won an R&D 100 Award for its Atlas Platform

Nirrin Technologies, a developer of analytical tools poised to transform bioprocess analysis, won an R&D 100 Award for their Atlas application, an analytical platform powered by Near Infrared High-Precision Tunable Laser Spectroscopy.

Atlas provides bioprocess teams rapid, at-line insights. Only 15 µL of sample gets you data for excipients, surfactants, high-concentration proteins, and monoclonal antibodies simultaneously in under one minute to move forward faster with confident decisions.

ANZU PARTNERS UPDATES

Upcoming Events

Anzu representatives plan to attend the following events:

• ACTUATE 2025 – September 23-24, 2025 – San Francisco
• NDIA Future Force Capabilities – September 30 – October 3, 2025 – Fort Worth, TX
• Battery Show North America – October 6-9, 2025 – Detroit, MI
• High Tech Venture Days Europe – October 14-15, 2025 – Dresden
• Tough Tech Summit – October 28, 2025 – Boston, MA

Please reach out to info@anzupartners.com if you’re interested in meeting with us at any of these events.

ADDITIONAL PC MEDIA COVERAGE

• Anzu Partners earned a place on Time Magazine’s** Top American Venture Capital Firms list for 2025.
• GelSight was featured in another video by science YouTuber Steve Mould, highlighting how its technology can help generate more accurate measurements.
• Niron Magnetics earned local MN coverage in WJON for its new production facility in Sartell.
• XGS Energy VP and Head of Development Logan Stephens was featured in an Albuquerque Journal article regarding New Mexico’s geothermal potential.
• EnCharge AI CEO Dr. Naveen Verma was featured on an episode of the SAE Media Group podcast to spotlight its in-memory computing chip. EnCharge was also featured in a TechCrunch article on AI startups that have raised more than $100M in 2025.
• Liquid Instruments’ new Moku:Delta system was featured in Electronicsforu.
• e-Zinc was featured in a Tech News 180 story about the top cleantech startups.
• Xendee was featured in a Solar Builder piece on a solar sales and design software.
• Voltaiq was featured in an Auto Service World piece on emerging opportunities in the EV battery industry.

*Requires subscription to read

** TIME and Statista ranked 350 VC firms based on their fundraising strength in the last five years, their investment capacity, as well as the volume and efficiency of their exits through IPOs and acquisitions. Applications are a key part of the project’s selection process. The rankings were published on August 19, 2025. 

 Join Our Ecosystem 

Anzu Partners and our portfolio companies are growing, and we’re always looking for exceptional talent. Whether you're seeking new career opportunities or exploring ways to collaborate, we invite you to connect with us and become part of our network.

FOLLOW US

To stay up to date on the latest news from both Anzu and our portfolio companies, follow us on social media.

ABOUT ANZU PARTNERS

Anzu Partners is an investment firm that focuses on industrial and life science technology companies with the potential to transform their industries. Anzu works with entrepreneurs to develop and commercialize technological innovations by providing capital alongside deep expertise in business development, market positioning, intellectual property, global connectivity, and operations. For more information, please visit https://anzupartners. com/.